(Q34082299)

30 July 2017

1 reference

title

Pharmacology and potential mechanisms of action of rizatriptan (English)

1 reference

30 July 2017

1 reference

R J Hargreaves

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

20 Suppl 1

1 reference

30 July 2017

page(s)

2-9

1 reference

Brain stem activation in spontaneous human migraine attacks

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.020S1002.X

Experimental cranial pain elicited by capsaicin: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.020S1002.X

Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.020S1002.X

Pharmacokinetics of rizatriptan tablets during and between migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.020S1002.X

Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.020S1002.X

Coronary side-effect potential of current and prospective antimigraine drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.020S1002.X

Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.020S1002.X

The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.020S1002.X

Rizatriptan has central antinociceptive effects against durally evoked responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.020S1002.X

Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.020S1002.X

10.1046/J.1468-2982.2000.020S1002.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference